# Novo Nordisk CEO Faces Tough Questions on Ozempic and Wegovy Prices in US ### Key Points: – Novo Nordisk CEO faced questioning from Congress regarding the prices of Ozempic and Wegovy in the US. – Ozempic and Wegovy are two popular weight loss medications produced by Novo Nordisk. – Lawmakers raised concerns about the high costs of these medications for American consumers. – The company defended its pricing strategy, citing the investments and innovation behind the drugs. Novo Nordisk CEO found himself in the hot seat as he was questioned by Congress regarding the pricing of two of the company’s weight loss medications, Ozempic and Wegovy, in the United States. Lawmakers expressed concerns over the high prices of these drugs and the impact it has on American consumers. Despite the intense scrutiny, the company stood by its pricing strategy, emphasizing the significant investments and research that have gone into developing these innovative medications. If you are considering weight loss medications like Ozempic or Wegovy, it’s essential to consult with professionals to understand your options fully. Mindful Evolution offers telehealth services in various states, including Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia. Contact Mindful Evolution to learn more about how we can support you on your weight loss journey. Weight Loss Disclaimer: Before starting any weight loss medication or program, consult with a healthcare provider to determine the best approach for your individual needs and circumstances.